home / stock / aim / aim news

AIM News and Press, AIM ImmunoTech Inc. From 09/24/20

Stock Information
Company Name: AIM ImmunoTech Inc.
Stock Symbol: AIM
Market: NYSE
Website: aimimmuno.com
Menu
AIM AIM Quote AIM Short AIM News AIM Articles AIM Message Board
Get AIM Alerts

News, Short Squeeze, Breakout and More Instantly...
AIM - NKLA, GLNG leads the premarket losers pack

Kubient KBNT -21% on Q2 2020 Results Earnings call.Nikola  NKLA -12% after WSJ warns on stalled talks with potential partners.NanoVibronix (NAOV) -10%.Golar LNG  (GLNG) -9%.Digital Ally (DGLY) -8%.DiamondPeak Holdings (DPHC) -8%.AIM ImmunoTech  (AIM) -7%.Pen...
AIM - 3 Penny Stocks To Buy & 1 To Hold According To These Analysts

Are Analysts Correct About These Penny Stocks To Buy Right Now? Penny stocks are some of the most interesting types of stocks to watch. This is the case for several reasons. For one, these stocks are known to be quite volatile. For those who use day or swing trading, volatility is p...

AIM - NanoVibronix, AIM ImmunoTech leads healthcare gainers, Vaccinex, BioSig Technologies among major losers

Gainers: NanoVibronix (NAOV) +98%, AIM ImmunoTech (AIM) +29%, Rockwell Medical (RMTI) +22%, Aurora Cannabis (ACB) +16%, Allied Healthcare Products (AHPI) +15%.Losers: Vaccinex (VCNX) -56%, BioSig Technologies (BSGM) -30%, ADC Therape...

AIM - GME, CVNA, WPRT and SOL among midday movers

Gainers: NanoVibronix (NAOV) +106%.Carvana (CVNA) +33%.AIM ImmunoTech (AIM) +25%.GameStop (GME) +21%.Boxlight (BOXL) +20%.Rockwell Medical (RMTI) +20%.Blink Charging (BLNK) +19%.Natural Alternatives International (NAII) +18%.Issuer Direct (ISDR) +17%.Renren (RENN) +16%.Losers:&...
AIM - AIM ImmunoTech's Ampligen extends survival in pancreatic cancer patients

AIM ImmunoTech (AIM) jumps 35% premarket on robust volume in reaction to its announcement of results from an Ampligen multiyear early access program in the Netherlands for pancreatic cancer patients.A medical team at Erasmus University Medical Center ((EUMC)) reported a significant ...

AIM - AIM ImmunoTech Receives Statistically Significant Positive Survival Results in Pancreatic Cancer from Erasmus University Medical Center, Rotterdam, Netherlands

Median survival approximately two-fold higher in Ampligen arm compared to historical controls; AIM to seek FDA Fast Track designation and orphan drug status in late stage pancreatic cancer OCALA, FL / ACCESSWIRE / September 22, 2020 / AIM ImmunoTech Inc. (NYSE American:AIM) today announ...

AIM - AIM ImmunoTech/Roswell Park initiates enrollment in combo trial in COVID-19 patients with cancer

AIM ImmunoTech (NYSEMKT: AIM ) begins recruitment in Roswell Park Comprehensive Cancer Center's Phase 1/2a clinical study of the effectiveness of rintatolimod (Ampligen) in combination with interferon alpha-2b in treating cancer patients with mild or moderate COVID-19. More news on: AI...
AIM - AIM ImmunoTech Highlights Start of Recruitment in Roswell Park Clinical Trial Incorporating Ampligen in the Treatment of Cancer Patients with Mild or Moderate COVID-19

OCALA, FL / ACCESSWIRE / September 16, 2020 / AIM ImmunoTech Inc. (NYSE American:AIM) today announced that recruitment has begun in Roswell Park Comprehensive Cancer Center's Phase 1/2a clinical study of the effectiveness of rintatolimod (Ampligen) in combination with interferon alpha-2b...

AIM - AIM ImmunoTech to Present at the H.C. Wainwright 22nd Annual Global Investment Conference on September 14th

OCALA, FL / ACCESSWIRE / September 10, 2020 / AIM ImmunoTech Inc. (NYSE American:AIM) today announced that the company will be presenting at the H.C. Wainwright Annual Global Investment Conference, being held virtually on September 14-16, 2020. Thomas K. Equels, Chief Executive Officer of A...

AIM - TSLA, ACB among premarket gainers

Intra-Cellular Therapies (ITCI  +74%  on positive topline results from its Phase 3 clinical trial. More news on: Astrotech Corporation, Vaxart, Inc., Chembio Diagnostics, Inc., Stocks on the move, , Read more ...

Previous 10 Next 10